3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
9
Recurrence
2
Neoplasms, Plasma Cell
2
Smoldering Multiple Myeloma
1
Neoplasm, Residual
1
Disease Progression
1
Disease
1
Interventions
Lenalidomide
4
Dexamethasone
4
Bortezomib
3
pomalidomide
2
Cyclophosphamide
2
ricolinostat
1
Zoledronic Acid
1
Vitamin D
1
Transplantation, Autologous
1
Melphalan
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Calcium Dobesilate
1
Calcium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Disease Progression
×
Transplantation, Autologous
×
Plasma cell
×
Clear all
NCT02043847
2024-11-13
BMT-03
University of Illinois at Chicago
Phase 1
Completed
12 enrolled
12 charts